bromopyruvate has been researched along with Experimental Hepatoma in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (66.67) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, EJ; Cho, H; Cho, YY; Kim, K; Kim, YJ; Lee, JH; Lee, YB; Yoon, JH; Youn, H; Yu, SJ | 1 |
| Huang, JH; Jiang, XY; Luo, RG; Miao, BJ; Wang, Y; Zhang, XP | 1 |
| Jin, Q; Li, Q; Liu, H; Pan, Q; Sun, Y; Wang, Q; Zhao, S | 1 |
| Acha-Ngwodo, O; Buijs, M; Engles, JM; Ganapathy-Kanniappan, S; Geschwind, JF; Khwaja, A; Liapi, E; Shanmugasundaram, G; Syed, L; Vali, M; Ventura, VP; Vossen, JA; Wahl, RL | 1 |
| Buijs, M; Geschwind, JF; Kutiyanwala, F; Kutiyanwala, M; Syed, L; Vali, M; Vossen, JA | 1 |
| Buijs, M; Ganapathy, S; Ganapathy-Kanniappan, S; Geschwind, JF; Khwaja, AA; Liapi, E; Prieto-Ventura, V; Vali, M; Vossen, JA; Wahl, RL | 1 |
| Geschwind, JF; Ko, YH; Magee, C; Pedersen, PL; Torbenson, MS | 1 |
| Hullihen, J; Ko, YH; Pedersen, PL; Pomper, MG; Rini, DA; Smith, BL; Torbenson, MS; Wang, Y | 1 |
| Choi, D; Choo, IW; Choo, SW; Do, YS; Han, H; Kim, SS; Lee, DH; Lee, JH; Lee, JY; Park, CK; Shin, SW; Yoo, BC | 1 |
| Georgiades, C; Geschwind, JF; Hong, K; Khwaja, A; Kowalski, J; Liapi, E; Torbenson, MS; Vali, M | 1 |
| Cheon, GJ; Jeong, JM; Kim, W; Lee, HS; Lee, TS; Park, SC; Yang, JI; Yoon, JH | 1 |
| Geschwind, JF; Ko, YH; Pedersen, PL | 1 |
12 other study(ies) available for bromopyruvate and Experimental Hepatoma
| Article | Year |
|---|---|
Carbonic anhydrase-IX inhibition enhances the efficacy of hexokinase II inhibitor for hepatocellular carcinoma in a murine model.
Topics: Acetazolamide; Animals; Antigens, Neoplasm; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carcinoma, Hepatocellular; Hep G2 Cells; Hexokinase; Humans; Liver Neoplasms, Experimental; Male; Mice, Inbred BALB C; Mice, Nude; Pyruvates | 2019 |
[Effects of intra-arterial infusion of 3-bromopyruvate on metastases and survival benefit of hepatic VX2 tumor in rabbits].
Topics: Animals; Liver Neoplasms, Experimental; Neoplasm Metastasis; Pyruvates; Rabbits; Survival Analysis | 2013 |
Hepatotoxicity and nephrotoxicity of 3-bromopyruvate in mice.
Topics: Acute Kidney Injury; Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Kidney; Liver; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Pyruvates | 2016 |
Targeting of VX2 rabbit liver tumor by selective delivery of 3-bromopyruvate: a biodistribution and survival study.
Topics: Animals; Carbon Radioisotopes; Fluorodeoxyglucose F18; Infusions, Intra-Arterial; Liver Neoplasms, Experimental; Pyruvates; Rabbits; Tissue Distribution | 2008 |
Development of a new orthotopic animal model of metastatic liver cancer in the rabbit VX2 model: effect on metastases after partial hepatectomy, intra-arterial treatment with 3-bromopyruvate and chemoembolization.
Topics: Animals; Chemoembolization, Therapeutic; Disease Models, Animal; Hepatectomy; Infusions, Intra-Arterial; Liver Neoplasms, Experimental; Lung Neoplasms; Pyruvates; Rabbits | 2008 |
Assessment of tumoricidal efficacy and response to treatment with 18F-FDG PET/CT after intraarterial infusion with the antiglycolytic agent 3-bromopyruvate in the VX2 model of liver tumor.
Topics: Angiography; Animals; Enzyme Inhibitors; Fluorodeoxyglucose F18; Image Processing, Computer-Assisted; Infusions, Intra-Arterial; Liver; Liver Circulation; Liver Neoplasms, Experimental; Male; Neoplasm Transplantation; Pharmaceutical Solutions; Positron-Emission Tomography; Pyruvate Dehydrogenase Complex; Pyruvates; Rabbits; Radiopharmaceuticals; Tomography, Emission-Computed | 2011 |
Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Cell Division; Cell Survival; Embolization, Therapeutic; Injections, Intra-Arterial; Liver Neoplasms, Experimental; Lung Neoplasms; Neoplasm Transplantation; Pyruvates; Rabbits | 2002 |
Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP.
Topics: Adenosine Triphosphate; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Enzyme Inhibitors; Female; Glucose; Humans; Liver Neoplasms, Experimental; Neoplasm Transplantation; Pyruvates; Rats; Rats, Sprague-Dawley; Survival Rate | 2004 |
Hepatic intra-arterial injection of 3-bromopyruvate in rabbit VX2 tumor.
Topics: Animals; Enzyme Inhibitors; Hepatic Artery; Injections, Intra-Arterial; Liver Neoplasms, Experimental; Neoplasm Transplantation; Pyruvates; Rabbits; Statistics, Nonparametric | 2006 |
Intraarterial therapy with a new potent inhibitor of tumor metabolism (3-bromopyruvate): identification of therapeutic dose and method of injection in an animal model of liver cancer.
Topics: Animals; Antineoplastic Agents; Catheterization; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hepatic Artery; Infusions, Intra-Arterial; Injections, Intra-Arterial; Liver Neoplasms, Experimental; Maximum Tolerated Dose; Pyruvate Dehydrogenase Complex; Pyruvates; Rabbits | 2007 |
Apoptosis-inducing antitumor efficacy of hexokinase II inhibitor in hepatocellular carcinoma.
Topics: Animals; Annexin A5; Apoptosis; Azirines; Carcinoma, Hepatocellular; Enzyme Inhibitors; Flow Cytometry; Hexokinase; Humans; Hypoxia; Immunoblotting; Immunoprecipitation; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C3H; Mitochondria; Phosphatidylcholines; Pyruvate Dehydrogenase Complex; Pyruvates; Tissue Distribution; Tumor Cells, Cultured | 2007 |
Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase.
Topics: Animals; Antimetabolites; Antineoplastic Agents; Cell Survival; Deoxyglucose; Drug Delivery Systems; Enzyme Inhibitors; Glucose; Glycolysis; Hexokinase; Kinetics; Lactic Acid; Liver; Liver Neoplasms, Experimental; Phenotype; Pyruvates; Rabbits | 2001 |